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Helicobacter pylori CagL dependent induction of
gastrin expression via a novel avb5-integrineintegrin
linked kinase signalling complex
Tobias Wiedemann,1 Stefan Hofbaur,1 Nicole Tegtmeyer,2 Sylwia Huber,3
Norbert Sewald,3 Silja Wessler,4 Steffen Backert,2 Gabriele Rieder1,4
ABSTRACT
Objective One of the most important hormones in the
human stomach is the peptide gastrin. It is mainly
required for the regulation of gastric pH but is also
involved in growth and differentiation of gastric epithelial
cells. In Helicobacter pylori infected patients, gastrin
secretion can be upregulated by the pathogen, resulting
in hypergastrinaemia. H pylori induced hypergastrinaemia
is described as being a major risk factor for the
development of gastric adenocarcinoma.
Design In this study, the upstream receptor complex
and bacterial factors involved in H pylori induced gastrin
gene expression were investigated, utilising gastric
epithelial cells which were stably transfected with
a human gastrin promoter luciferase reporter construct.
Results Integrin linked kinase (ILK) and integrin b5, but
not integrin b1, played an important role in gastrin
promoter activation. Interestingly, a novel CagL/integrin
b5/ILK signalling complex was characterised as being
important for H pylori induced gastrin expression. On
interaction of H pylori with avb5-integrin and ILK, the
epidermal growth factor receptor (EGFR)
/Raf/mitogen activated protein kinase kinase
(MEK)/extracellular signal regulated kinase (Erk)
downstream signalling cascade was identified which
plays a central role in H pylori gastrin induction.
Conclusion The newly discovered recognition receptor
complex could be a useful target in treating
precancerous conditions triggered by H pylori induced
hypergastrinaemia.
INTRODUCTION
Helicobacter pylori is a gram negative, spiral shaped
bacterium that colonises the gastric mucosa of
approximately 50% of the world’s population. This
pathogen causes gastritis, peptic ulcer and, in some
cases, gastric adenocarcinoma and mucosa associ-
ated lymphoid tissue lymphoma.1 2 Gastric cancer
is the fourth leading cancer causing death world-
wide. In 1994, the WHO declared H pylori as a class
I carcinogen based on epidemiological studies.
H pylori strains harbouring the cytotoxin associated
gene pathogenicity island (cagPAI) and certain
alleles of the vacuolating cytotoxin (VacA) are more
virulent than strains deficient in both virulence
factors.3e5 The cagPAI encodes a functional type IV
secretion system (T4SS) to inject the effector
protein CagA into host target cells6 where it is
phosphorylated by Src and Abl kinases.7 8 Both
phosphorylation dependent and independent
signalling mechanisms of injected CagA have been
described, such as activation of proinflammatory
cytokines, cell proliferation, motility and elonga-
tion.9 A recent study indicated that CagL, a VirB5
orthologue, is located at the tip of the T4SS pilus
and interacts with the integrin a5b1 receptor of the
gastric epithelial cells via an Arg-Gly-Asp (RGD)
motif.6 CagL has been also shown to activate
epidermal growth factor receptor (EGFR) and is
essential for injection of CagA into gastric epithelial
cells.10
Gastrin is one of the most important peptide
hormones in the human stomach. It was first
described in 1906 as a tissue factor which stimu-
lates acid secretion in the corpus mucosa.11 Gastrin
is released into the gastric vasculature from
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Significance of this study
To investigate the H pylori induced gastrin promoter
activation, the bacterial ligand and its host receptor
as well as the signalling pathway upstream of the
promoter.
What is already known about this subject?
< H pylori induces the gastrin promoter.
< The induction proceeds in a CagA and VacA
independent manner.
< The actual H pylori factor inducing gastrin is
unknown.
What are the new findings?
< H pylori CagL is a novel ligand activating the
gastrin promoter.
< CagL is interacting with avb5-integrin to
activate gastrin expression via integrin linked
kinase (ILK) signalling complex.
< The upstream signalling pathway of the gastrin
promoter involves the epidermal growth factor
receptor (EGFR) / Raf cascade leading to
mitogen activated protein (MAP) kinase activation.
How might it impact on clinical practice in the
foreseeable future?
< This newly discovered interaction partner CagL/
b5-integrin could be a useful target in treating
gastric precancerous conditions triggered by
H pylori induced hypergastrinaemia.
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endocrine G cells in the antrum in response to food intake.
Gastrin binds to cholecystokinin 2 receptors on enterochro-
maffin-like cells to stimulate histamine release and also binds to
cholecystokinin 2 receptors on parietal cells to activate acid
secretion in corpus tissue.12 13 Histamine stimulates adjacent
parietal cells through histamine 2 receptors and thus activates
acid secretion also. It is well established that epidermal growth
factor (EGF) binds to its receptor EGFR activating the gastrin
promoter via the mitogen activated protein (MAP) kinase
members, mitogen activated protein kinase kinase (MEK) and
extracellular signal regulated kinase (ERK) 1/2.14 15
Studies in diverse animal models, usage of various human
gastric cancer cell lines and the exploration of human biopsies
established gastrin as a type of growth factor which affects
proliferation, apoptosis, migration, invasion, tissue remodelling
and angiogenesis both in vitro and in vivo.16e23 INS-GAS and
GAS-KO mice models are two animal models frequently used to
investigate the physiological and pathological role of gastrin.
INS-GAS mice which overexpress human amidated gastrin
(GAS) under an insulin (INS) promoter exhibit initial gastric
mucosal hypertrophy and excess gastric acid secretion. Gastrin
deficient (GAS-KO) mice are achlorhydric due to a severe
impairment of acid secretion. After 5 months, the INS-GAS mice
display progressive changes in histology and physiology and
after 20 months they are essentially achlorhydric and all animals
develop gastric dysplasia. When these hypergastrinaemic mice
were infected with H pylori expressing both CagA and VacA
(cagA+/vacA+) they developed gastric adenocarcinoma after
7 months of infection.24 25 However, in contrast with the INS-
GAS mice, GAS-KO mice are characterised by reduced parietal
cell numbers and are predisposed to bacterial colonisation and,
therefore, are often overgrown by multiple bacterial species.26e29
When these mice are infected with cagA+/vacA+ H pylori, there
is an alteration in acid secretion, thought to be stimulated by
a vagal response mechanism, but no increased risk of tumour
development is observed after 6 months.30 The absence of
capacity for increased tumour development observed could be
attributed to the lack of gastrin and its mitogenic function.
Mongolian gerbils are another useful model system to study
H pylori induced gastric pathology. In our recently published
study, gerbils were infected with the H pylori wild-type (WT)
strain B8 which expresses a functional T4SS for injection and
phosphorylation of CagA,31 and an isogenic T4SS mutant strain
B8DcagY (also called DvirB10) which is not able to translocate the
CagA into the host cells. The results revealed early (4e8 weeks)
T4SS dependent inflammation only in WT infected animals that
was followed by severe active and chronic gastritis, mucous gland
metaplasia and dysplasia. Interestingly, WT infected animals
exhibited hypochlorhydria after 16 weeks and hypergastrinaemia
after 32 weeks post infection but none of the mutant infected
mice did. To summarise these observations, we assert that the
early proinflammatory responses (increase in interleukin (IL)-1b,
interferon g, tumour necrosis factor a, IL-6 and keratinocyte-
derived cytokine) are major drivers for physiological changes such
as hypochlorhydria and hypergastrinaemia.32 33
To date, the role of H pylori in the pathology of developing
gastritis, disturbed acid and gastrin homeostasis was not well
understood. Recently, it was shown that live H pylori are able to
target the gastrin promoter through GC-rich DNA elements.34
However, it is not clear which H pylori factor is responsible for
activating the gastrin promoter and which downstream signal-
ling cascades are involved. Hence in the present study, we
investigated in detail the molecular mechanisms of H pylori
induced gastrin expression. To explore the regulation of
the human gastrin gene by H pylori, we used an in vitro approach
with AGS gastric epithelial cells stably transfected with a human
gastrin promoter luciferase reporter construct (GAS-Luc). Our
main interests were to systematically identify the H pylori ligand,
its binding partner on the cell surface as well as the signalling
cascade involved in inducing the human gastrin promoter.
MATERIAL AND METHODS
Bacterial strains and culture conditions
H pylori P12, B8, 7.13, P1, 26695, J99, Tx30a, Ka12535 and 106136
were grown on GC agar plates (Oxoid, Vienna, Austria)
supplemented with horse serum (5%), vancomycin (10 mg/ml),
trimethoprim (5 mg/ml) and nystatin (1 mg/ml) (serum plates)
and incubated for 2e3 days in a microaerobic atmosphere (85%
N2, 10% CO2, 5% O2) at 378C. E coli strain DH5a (BRL) was
grown on LuriaeBertani (LB) agar plates under oxic conditions
at 378C. Campylobacter jejuni C6437 was grown at 378C on
Columbia blood agar plates with sheep blood plus (Oxoid) under
microaerobic conditions. Re-isolates out of gastric mucosa of
Mongolian gerbils were verified with a positive urease (urea
broth, Oxoid), oxidase (DrySlide, BBL), and catalase (3%
hyperperoxid solution) activity and streptomycin resistance.
Materials, reagents and antibodies
Anti-ß2-integrin (blocking, MAB1388Z), anti-avß3-integrin
(blocking, MAB2023Z), anti-ß4-integrin (blocking, MAB2058Z),
anti-avb5-integrin (blocking, MAB1961Z), anti-aV-integrin anti-
bodies and cell culture inserts were purchased from Millipore
(Schwalbach, Germany). Anti-IL1ß (neutralisation, I3642), anti-
integrin linked kinase (ILK) and IL-8 were purchased from Sigma-
Aldrich (Taufkirchen, Germany). Inhibitors ZM336372, PD98059,
SB203580, Gefitinib and AG1478 were purchased from Merck
(Vienna, Austria). The phospho-tyrosine specific antibody PY99,
anti-Erk, anti-p38, anti-focal adhesion kinase (FAK) and anti-
GAPDH were purchased from Santa Cruz (Heidelberg,
Germany). For the experiments in figure 6C, the phospho specific
antibodies anti-EGFR-PY-845, anti-Raf-PS-259, anti-MEK-PS-217/
221 and anti-ERK-PT-202/PY-204 were purchased from NEB Cell
Signalling (Frankfurt, Germany). Pro- and anti-inflammatory
cytokines IL-1b, interferon g, tumour necrosis factor a, IL-4 and
IL-10 were purchased from ImmunoTools (Friesoythe, Germany).
Antibodies against phospho-p38 and phospho-Erk were
purchased from Cell Signalling. The antibody against CagA,38
anti-ß1-integrin (blocking, AIIB2), and the purified VacA39 were
kindly provided by the laboratory of Rainer Haas (Max-von-
Pettenkofer Institute, Munich, Germany). Anti-ß7-integrin anti-
body (blocking, 121004) was purchased from BioLegend (Fell,
Germany). As western blot loading control, an anti-a-tubulin
antibody (Upstate, Frankfurt, Germany) was used.
Construction of DcagL and DcagY mutants
Standard techniques were used for routine DNA manipulation,
subcloning and plasmid construction, as previously described by
Sambrook and Russell.40 The DcagY mutant was constructed as
previously described.33 To produce a H pylori B8 DcagL mutant,
the plasmid pSH6 was constructed. pSH6 carries a kanamycin
cassette in a XbaI site between two adjacent nucleotide regions
of about 1000 bp up and down stream of the cagL gene. The PCR
products were generated by using genomic DNA from H pylori
B8 strain applying the primers for 59-cagL fragment: FP 59-CGG
AGC TCA GGT TCA GAC ATC TTG CTT GG-39 and RP
59-GCT CTA GAG CAT CTT CTT CAC CCA TTT C-39 and
39-cagL fragment: FP 59-CCT CTA GAG CCA ATT TTG AAG
CGA ATG AG-39 and RP 59-CGG AAT TCG ACA ACA CTT
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GAG TGG TTTAAA AC-39. The amplified products were cloned
into the restriction sites ScaI and EcoRI of pBluescript SK+
(Stratagene, La Jolla, California, USA).
The resulting plasmid was transformed into E coli DH5a and
the re-isolated plasmid (QIAprep Spin Miniprep Kit, Qiagen,
Hilden, Germany) subjected to DNA sequencing to verify
sequence integrity.
The deletion mutant was obtained by transforming the
constructed plasmid pSH6 into the natural competent H pylori
B8 cells kept in liquid culture medium (Brucella broth plus 10%
fetal calf serum). The transformed bacteria were selected on
serum plates supplemented with kanamycin. The P12cagL-RGD
mutants were constructed as previously described.41
In vitro gastrin promoter stimulation assay
AM0 cells are AGS cells stably transfected with a plasmid
containing 240 base pairs of the human gastrin promoter
expressing the luciferase reporter (240 GasLuc).42 AM4 cells
express the 240 GasLuc construct with a 4 base pair mutation
within the GC-rich element preventing EGF responsiveness
(gERE) to the gastrin promoter.43 AM4 cells equally treated
served as negative controls. Both cell lines were cultured in RPMI
1640 (Gibco BRL, Darmstadt, Germany) supplemented with
horse serum (10%) under standard conditions. Cells at 70%
confluence and starved for 24 h in Nutrient Mixture F12 (HAM;
Gibco) without supplements were stimulated with bacterial
suspensions of WT and mutant strains at a multiplicity of
infection of 100:1 (bacteria per cell) or purified VacA and CagL for
5 h. Cells were harvested in lysis buffer (14 g/l K2HPO4, 2.67 g/l
KH2PO4, 0.74 g/l EDTA, 1 g/l Triton X-100, 1 nM DTT), and
luciferase activity was measured (MicroLumat Plus LB 96 V;
Berthold Technologies, Bad Wildbad, Germany) and normalised
to total cell protein. Blocking antibodies and inhibitors were
preincubated 45 min before bacterial stimulation. To generate
metabolic inactive bacteria, pretreatment with 0.15% NaN3 was
carried out for 20 min.
Purification of recombinant CagL
To clone WT CagL for protein expression in E coli, a PCR product
corresponding to amino acid residues 21e237 of the protein
(minus the predicted signal sequence) was cloned into the pET-
28a vector (Novagen, Darmstadt, Germany) and sequenced. The
CagL-RGA mutant was constructed using the QuickChange
mutagenesis kit (Novagen, Vienna, Austria). WT and RGA
mutant CagL were overexpressed and purified by means of
63His tag applying a standard protocol, as described previously.6
In brief, E coli strain BL21 (DE3) harbouring the CagL vectors
was grown in 5 ml of LB medium at 378C overnight. Then
500 ml of fresh LB medium were added and shaken for about 3 h
until OD600¼1. IPTG (1 mM) was added and the bacteria were
grown for another 2 h to induce CagL protein expression.
Bacterial pellets were harvested, pelleted by centrifugation and
then resuspended in ice cold CW buffer (50 mM KH2PO4-
K2HPO4, pH 7.5, 200 mM NaCl) supplemented with protease
inhibitor cocktail (Roche, Dublin, Ireland). After sonication,
CagL protein present in the inclusion bodies was solubilised in
buffer LW (50 mM KH2PO4-K2HPO4, pH 7.5, 200 mM NaCl,
6 M guanidine hydrochloride) and refolded in ice cold refolding
buffer (52 mM Tris HCl, pH 8.2, 20 mM NaCl, 834 mM KCl,
1.1 mM EDTA, 2.1 mM reduced glutathione, 210 mM oxidised
glutathione). CagL proteins were then further purified through
Talon resin affinity chromatography (BD Biosciences, Heidelberg,
Germany) and gel filtration in buffer CW through Sephacryl
S-200 (16/60) according to the suppliers’ recommendation
(Pharmacia Biosciences, Munich, Germany). CagL protein
concentrations were measured by BCA protein assay (Pierce,
Dublin, Ireland), typically yielding a total amount of about
1.5 mg CagL in 10 ml of buffer. Purification of CagL was judged
to be of >95% homogeneity by SDS-PAGE/Coomassie Blue
staining. The folded conformation of the purified CagL proteins
was confirmed by circular dichroism.6 No indication of post-
translational modifications of purified CagL such as disulphide
formation or methylation was detected.10
Binding of CagL to integrin avb5 determined by Biacore surface
plasmon resonance
Purified integrin avb5 (Chemicon, Darmstadt, Germany) was
immobilised by amino coupling to the surface of a CM5
carboxymethyl dextran sensorchip. The analysis was performed
as described previously.6 Data were processed using the Biae-
valuation software (V.4.1).
In vitro assays of AGS cells with recombinant CagL
Assays for the interaction of AGS cells with purified CagL were
performed according to procedures described previously.10
Briefly, six well plates were coated overnight at 48C with 100 ml
of 50 mg/ml purified CagL or BSA (Sigma, Vienna, Austria) in
buffer CW as control. Non-specific binding sites were then
blocked with 5% bovine serum albumin (BSA) in buffer CW for
2 h at 378C. The AGS cells were grown as described above,
trypsinised and then treated with soybean trypsin inhibitor
according to the protocol of the manufacturer (Sigma). After
washing with phosphate buffered saline, 43105 AGS cells in
RPMI were added to the wells and incubated for 3 h. In this time
period, AGS cells attached to immobilised CagL (but not BSA)
and the cells were harvested with a cell scraper, pelleted by
centrifugation and resolved in 13 SDS-PAGE buffer for western
blot analyses.
Plasmid transfection
Low passage AGS cells with 40e50% confluency were trans-
fected with either pSP65SR+ or pSP65SR+CagA and 240GasLuc
for 24 h using Lipofectamine 2000 (Invitrogen, Darmstadt,
Germany) and Genejuice Tranfection Reagent (Novagen),
respectively, according to the manufacturer`s instructions. The
CagA overexpression plasmid pSP65SR+CagA contains the cagA
gene of H pylori strain NCTC11637 which was cloned into basic
vector pSP65SRa.44
RNA interference
Low passage cells with 20e30% confluency were transfected
with 50 nM small interfering RNA (siRNA) using Lipofectamine
RNAiMAX Reagent (Invitrogen) according to the manufac-
turer ’s instructions. siRNA against FAK, ILK and control siRNA
(with an equal GC content) were purchased from Invitrogen
and (for figure 5D) from Santa Cruz. Three days after trans-
fection, cells were harvested and subjected to immunoblotting
and luciferase measurement.
RNA isolation and real time RT-PCR
Gastric epithelial cells were harvested 24 h post transfection
with FAK or ILK siRNA in RLT buffer (Qiagen RNeasy Mini Kit)
with 1% ß-mercaptoethanol. RNA isolation was performed as
described in the Qiagen RNeasy Mini Kit protocol. Using the
TaqMan reverse transcription reagents (Roche) with random
primers according to the kit protocol, 1 mg mRNA was tran-
scribed into cDNA. Oligonucleotide primers specific for FAK, ILK
and the housekeeping gene 18S rRNA were applied for real time
RT-PCR (ABI PRISM 7000, Applied Biosystems, Darmstadt,
Germany). For amplification, the FastStart Universal SYBR
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Green Master (ROX) kit (Roche) was used according to the
manufacturer ’s instructions. All data were normalised with the
corresponding 18S rRNA transcription level using a comparative
delta Ct method.
Immunoblotting
Cells were harvested in lysis buffer (PhosSTOP (Roche) phos-
phatase inhibitor cocktail tablets resolved in DPBS (Gibco) by
scraping). These cell lysates were boiled in Laemmli sample
buffer for 10 min. Boiled samples were subjected to SDS-PAGE
using a minigel apparatus (Bio-Rad, Munich, Germany) and
blotted onto a PVDF membrane using a semi-dry blot system
(Biotec Fischer, Reiskirchen, Germany). The membranes were
blocked with either 5% milk powder or 3% BSA in TBS buffer
(50 mM Tris HCl, pH 7.5, 150 mM NaCl) and incubated over-
night with the respective primary antibody at 48C followed by
secondary antirabbit IgG or antimouse IgG conjugated HRP for
1 h at room temperature. Immunoreactive bands were detected
by ECL and radiography.
Animals and infection experiments
Specific pathogen free Mongolian gerbils (n¼20 females) were
infected as previous described.32 Animals were challenged
orogastrically with approximately 109 H pylori suspended in
Brucella broth. All experiments and procedures carried out were
conducted in accordance with the Guidelines for the Care and
Use of Laboratory Animals and approved by the Regierung von
Oberbayern (AZ 55.2-1-54-2531-78/05). The animals were
sacrificed after 8 weeks of infection, the stomach opened along
the greater curvature and the gastric tissue conserved in antrum
and corpus separately.
Statistics
Data are presented as mean6SEM. The results (raw data) were
statistically analysed using the Student t test with SigmaStat
statistical software (***p#0.001; **p#0.01; *p#0.05 were
considered significant; #p>0.05 was considered not significant).
RESULTS
H pylori strains with functional T4SS specifically induce the
gastrin promoter
Earlier reports showed that H pylori infected patients exhibited
elevated serum gastrin concentrations relative to control popu-
lations.45 46 In line with these observations, H pylori eradication
in humans was accompanied by reduction of gastrin concentra-
tions. To better understand how gastrin expression is influenced
by H pylori, an in vitro gastrin promoter study was performed.
We used AGS gastric epithelial cells that were stably transfected
with a luciferase reporter construct regulated by the human
gastrin WT gene promoter (AM0) to examine human gastrin
expression. In the first set of experiments, the cells were stimu-
lated with different bacteria and, subsequently, gastrin promoter
transactivation was determined. As a positive control, EGF,
a natural agonist for stimulation of gastrin gene expression,47
showed elevated gastrin activation as expected (figure 1). Inter-
estingly, clinical H pylori strains lacking the entire cagPAI (Tx30a,
Ka125 and 1061) showed a significantly reduced gastrin promoter
activation in contrast with all other applied WT strains
expressing the cagPAI, such as B8, P12, 7.13 and P1. Two other
cagPAI positive H pylori WT strains, 26695 and J99, also revealed
gastrin promoter activation but at moderate levels. As negative
controls, C jejuni and E coli, two bacterial species usually resident
in the gastrointestinal tract, were unable to activate the gastrin
promoter. Thus transcriptional activation of the gastrin promoter
in vitro appears to be a specific feature of H pyloriWTstrains that
express a functional T4SS in the cagPAI (figure 1).
Binding of H pylori strains is essential for gastrin promoter
activation
H pylori causes persistent infection in the gastric mucosa, which
is the major colonisation site for the bacterium. To explore
whether bacterial contact with gastric epithelial cells is neces-
sary to induce the gastrin promoter, filter inserts were used to
prevent contact between the bacteria and the cells. In this
experimental setting, WT H pylori were unable to induce
promoter activation, suggesting that direct bacterial contact is
necessary (figure 2A).
In a second step, we focused on the investigation of the
H pylori ligand that binds to the epithelial cells inducing acti-
vation of the gastrin promoter. As binding of bacteria to
epithelial cells is mainly mediated through its major adhesins
BabA, SabA and AlpA/B,48e50 we underlined the above obser-
vation by applying the corresponding adherence defective
mutants. Therefore, H pylori J99 WT and isogenic single and
double adhesin mutant strains were used to stimulate AM0 cells.
No differences in gastrin promoter induction between the J99
WT and its isogenic mutant strains were observed (figure 2B).
These results confirmed the above data that binding of H pylori
via the major adhesins BabA, SabA and AlpA/B is not required to
activate the gastrin signalling pathway. In agreement with
a previous study,34 a series of infection and transfection experi-
ments showed that CagA or VacA are also not required for
gastrin activation (see supplementary figure S1,51 52 available
online only).
Next, we investigated if vital and metabolically active H pylori
are required for elevated gastrin promoter activity during infec-
tion. To answer this question, we stimulated AM0 cells with
either heat killed or sonicated H pylori lysates. The results of
these experiments showed that neither heat killed nor sonicates
were able to induce gastrin activity (figure 2C). In the following
experiment, we prepared metabolically inactive H pylori cells by
preincubation with sodium azide (NaN3) resulting in structur-































Figure 1 Gastrin promoter activation is H pylori strain specific. AM0
cells were stimulated with H pylori strains, E coli and C jejuni. After
infection, cells were harvested and luciferase activity was determined.
Luciferase activities in relation to H pylori B8 wild-type (represents
100%; interpolated broken line) were plotted. The mean values 6 SEM
of at least three independent experiments are shown. Statistical analysis
(Student’s t test) was applied using SigmaStat software. ***p#0.001;
*p#0.05; #p>0.05. EGF, epidermal growth factor.
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H pylori were no longer able to actively translocate CagA, as
indicated by the absence of a phospho-CagA signal (figure 2D),
but these metabolically inactive bacteria induced gastrin
promoter activation similar to untreated H pylori WT (figure
2C). Taken together, these data indicate that a heat labil surface
component of H pylori other than the well known adhesins
BabA, SabA and AlpA/B or factors injected by the T4SS is
sufficient to induce profound gastrin promoter activity. This
indicates that a structural member of the cagPAI might be
involved in promoter activation.
H pylori CagL induces the gastrin promoter
To identify the surface component responsible for gastrin
promoter induction, we tested a series of H pylori mutants with
defects in structural components of the T4SS, such as DcagY or
DcagL. Interestingly, neither DcagY nor DcagL mutant was able
to trigger gastrin promoter activation (figure 3A). The DcagY
mutant was chosen because it can still produce CagL protein but
does not produce T4SS pili for protein exposure.53 This
suggested that T4SS itself or a pilus exposed protein could
trigger this signalling. A potential candidate was the CagL
protein that decorates the T4SS pilus surface and makes contact
with the integrin receptor.6 Importantly, complementation of
the DcagL mutant with the WT cagL gene restored promoter
activity to WT levels, indicating that CagL plays a crucial role in
gastrin promoter induction (figure 3A). In agreement with this
conclusion, we also found that addition of recombinant
CagL protein alone stimulated gastrin promoter profoundly
(figure 3B).
H pylori CagL induces gastrin promoter activity via binding to
avb5-integrin
The above results suggest that CagL via interaction with the
known integrin family member integrin a5b1 may trigger
Figure 2 Contact of viable H pylori
wild-type (WT) is essential for gastrin
induction. (A) Filter inserts (FI) were
placed in each well containing AM0
cells. H pylori B8 WT or B8DcagY
mutant strain were added. (B) AM0
cells were stimulated with H pylori J99
and isogenic adhesine mutant strains.
(C) Heat killed (hk) and sonicated (so) H
pylori B8 lysates, and NaN3 treated,
metabolic inactive were used to
stimulate AM0 cells. (D) Western blot
analyses of AM0 cells stimulated with
NaN3 treated, metabolic inactive H
pylori strains were performed to detect
translocated CagA using a phospho
specific antibody. The B8DcagY mutant
strain served as a negative control and
a-tubulin (Tub) as the loading control.
Luciferase activities in relation to (A, C)
H pylori B8 WT or (B) J99 (represents
100%; interpolated broken line) were
plotted. The mean values 6 SEM of at
least three independent experiments
are shown. Statistical analysis







































































































Figure 3 H pylori CagL is stimulating
the gastrin promoter. (A) AM0 cells
were stimulated with H pylori wild-type




activities in relation to H pylori WT
(represents 100%; interpolated broken
line) were plotted. (B) AGS cells
transiently transfected with the gastrin
promoter were stimulated with
recombinant CagL (0.5e50 mg/ml), and
luciferase activity presented. The mean values 6 SEM of at least three independent experiments are shown. Statistical analysis (Student’s t test) was
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downstream signalling leading to gastrin promoter activation.
Interestingly, we found in infection experiments using AM0 cells
preincubated with function blocking a-integrin antibodies
(figure 4A) that binding to integrin a5b1 is not required for
gastrin activation. We therefore tested a number of other func-
tion blocking antibodies for major integrins expressed on AGS
cells,6 including b2, b3, b4, b5 and b7 (figure 4A). Most strikingly,
preincubation of cells with the a-avb5-integrin blocking anti-
body significantly decreased gastrin promoter stimulation by
more than 50% while the other antibodies had almost no effect
(figure 4A). To make sure that CagL really interacted with
integrin a5b1 during infection, we infected cells with WT
H pylori, a DcagY (DvirB10) and DcagL mutant for 3 h followed
by immunoprecipitation (IP) with an a-CagL antibody
Figure 4 H pylori CagL binds to the
epithelial cell via avb5-integrin during
infection. (A) AM0 cells were
preincubated with anti-b-integrin
blocking antibodies (Ab) (10 mg/ml) and
stimulated with H pylori B8 strain.
Luciferase activities in relation to H
pylori B8 wild-type (WT) (represents
100%; interpolated broken line) were
plotted. The mean values 6 SEM of at
least three independent experiments
are shown. (B) Western blot detection
of a-CagL immunoprecipitation of AGS
cells stimulated with H pylori P12,
DvirB10 (DcagY) and DcagL mutant
applying a-CagL, b1, b2, b3, b4, b5
and b7 integrin antibodies. (C) Biacore
in vitro binding analysis of recombinant
WT CagL and CagLRGA mutant with
avb5 integrin (KD, dissociation
constant). (D) Western blot detection of
a-CagL immunoprecipitation of AGS
cells stimulated with H pylori P12 and
DcagL mutant complemented with
cagLRGA applying a-CagL, a-b1, a-b5
and a-aV integrin antibody. Relative
quantification of the bound integrin b1,
b5 and av (lower graph). (E) AM0 cells
were stimulated with H pylori P12,
isogenic P12DcagL mutant and
complemented strain, and P12cagL
strains with a deleted or mutated RGD
motif. Luciferase activities in relation to
H pylori B8 WT (represents 100%;
interpolated broken line) were plotted.
The mean values 6 SEM of at least
three independent experiments are
shown. Statistical analysis (Student’s t
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(figure 4B). The western blot with a-CagL antibody showed that
equal amounts of CagL protein were precipitated in each lane.
Stripping and reprobing of the blot with a-integrin b1 antibodies
confirmed that b1 integrin is indeed present in the IP complex
(figure 4B). Surprisingly, we also detected strong signals
for integrin member b5, weakly for b3, but not for b2 or b4
integrins. This suggests that CagL may trigger signalling via
interaction with another receptor, avb5-integrin, leading to
gastrin promoter activation.
CagL interacts with both a5b1-integrin and avb5-integrin
We have recently shown in Biacore in vitro binding studies that
recombinant WT CagL bound to a5b1 integrin with high affinity
(KD of 0.09 mM) whereas the CagLRGA mutant, in which the
aspartate residue in the RGD motif was substituted by alanine,
bound to a5b1 integrin with fourfold less affinity.6 To test if
CagL can bind in the same manner to avb5-integrin, we
performed Biacore binding studies using the same settings. The
results showed that WT CagL bound to purified avb5-integrin
with about the same affinity (KD of 0.20 mM) compared with
a5b1 integrin (figure 4C). Interestingly, the CagLRGA mutant
bound avb5-integrin with a similarly high affinity at a KD of
0.35 mM (figure 4C), suggesting that the latter interaction
proceeds in an RGD independent manner. In agreement with
these data and previously reported findings,6 we also observed
that infection with H pylori expressing a CagLRGA mutant bound
less to integrin b1. In contrast, in the same experiment, CagLRGA
bound about equally to integrin b5 compared with WT CagL. To
verify an RGD independent binding of CagL with integrin b5, we
infected cells with WT H pylori and a DcagL mutant comple-
mented with a cagLRGA mutated construct followed by IP with
a-CagL antibodies (figure 4D). In each experiment, equal
amounts of CagL were precipitated. The western blot analyses
with a-integrin b1 and b5 antibodies clearly showed a signifi-
cantly weaker and an equally intense band compared with the
WT infected cells, respectively (figure 4D). Furthermore,
reprobing of the IP with an a-av integrin antibody revealed
that the av subunit is also present in the complex, as proposed
(figure 4D).
CagL induces the gastrin promoter activity in an RGD
independent manner
As the RGD motif seems to be dispensable for interaction of
CagL with avb5-integrin, we next aimed to investigate if this is
also the case for signalling leading to gastrin promoter activa-
tion. For this purpose, we infected AM0 cells with WT H pylori
and a series of additional RGD mutants (CagLRGA, CagLRAD or
CagLDRGD). In agreement with the results above, we found that
each of these mutants substantially induced gastrin promoter
activation similar to that of WT bacteria (figure 4E). This further
underlines the fact that CagL plays a crucial role in gastrin
promoter activation in an RGD independent manner.
H pylori triggered host communication is mediated through
integrin linked kinase
Integrins are specialised receptors in focal adhesions which link
signalling from the extracellular matrix to intracellular
factors. ILK and FAK are the most important focal adhesion
components in mediating signals on b-integrin binding.54 To
analyse whether the binding of H pylori WT to avb5-integrin
triggers integrin signalling via FAK or ILK and eventually induces
gastrin promoter stimulation, an RNA interference approach was
established. siRNA was applied to achieve knockdown of
endogenous ILK and FAK levels in AM0 cells. Real time PCR
analyses revealed a knockdown efficiency of 80e90% on the
mRNA level for FAK and ILK siRNA (figure 5A). A subsequent
step was to confirm the knockdown of FAK and ILK on
the protein level by western blotting. Following optimisation,
after 72 h of siRNA transfection, neither ILK nor FAK proteins
could be detected which verified an effective knockdown
(figure 5B,D). AM0 cells were transfected with FAK or ILK siRNA
for 72 h and then stimulated with H pylori WT. Our results
established that downregulation of FAK did not abolish gastrin
promoter activity but slightly enhanced it. However, all samples
transfected with ILK siRNA showed a significant decrease in
gastrin promoter induction of more than 50% (figure 5C).
Therefore, we assume that induction of gastrin expression also
involves ILK as a downstream signalling component.
EGFR/Raf/MAP/Erk signalling cascade involved in gastrin gene
expression
Observations in various cell systems revealed that different
intracellular MAP kinase signalling pathways (ERK, JNK and
p38) downstream of membrane receptors may be involved in the
transmission of gastrin inducing cellular effects.55 In contrast
with the signalling pathways activated by gastrin, the signal
transduction leading to gastrin gene induction is not well char-
acterised.14 In a previous study it was suggested that H pylori
involves MAP kinase using inhibitors targeting MEK1, JNK and
p38.34 To obtain a deeper insight into the regulation of the
gastrin promoter by H pylori, we performed a detailed study of
the upstream signalling.
Therefore, in this part of the study, we stimulated AM0 cells
with H pylori WT, preincubated with kinase inhibitors against
Raf-1 (ZM336372), MAP kinase MEK1 (PD98059) and p38
(SB203580). The data clearly revealed the involvement of the
MAP kinase cascade (figure 6A). Western blot analysis showed
that, compared with the H pylori DcagY mutant strain, H pylori
WT activates the p38 signalling cascade to a higher extent. Erk
signalling in AM0 cells was induced comparably in H pylori WT
and H pylori B8DcagY mutant strains. The phosphorylation of
Erk was no longer detectable when the cells were preincubated
with the MEK1 kinase inhibitor PD98059 (figure 6B). Further
western blot analysis of AGS cells stimulated with recombinant
CagL protein clearly demonstrated activation of the signal
cascade Raf/MEK/Erk (figure 6C) transactivating the gastrin
promoter.
For several years it has been shown that EGF is a crucial
signalling molecule in the stimulation of gastrin promoter
activity via EGFR.34 Whether H pylori induced transactivation of
the gastrin promoter involves EGFR activation was investigated
in this part of the study. Western blot analysis of CagL stimulated
cells with a-phospho EGFR antibodies revealed EGFR as a candi-
date upstream receptor for the signal cascade involved in gastrin
promoter activation (figure 6C). To verify the involvement of the
EGFR in H pylori WT induced gastrin induction, we preincubated
AM0 cells with Gefitinib and AG1478, tyrosine kinase inhibitors
of the EGFR family resulting in significantly reduced luciferase
activity (figure 6D). In parallel, we utilised a neutralising a-EGF
antibody to bind free EGF which would also stimulate the gastrin
promoter via EGFR. However, H pyloriWTstrain was still able to
stimulate the gastrin promoter, independently of EGF (figure 6D).
These data suggest that the H pylori induced gastrin promoter
activation involves the phosphorylation of the EGF receptor
independent of its classical EGF stimuli.
Furthermore, we analysed the impact of ILK siRNA treat-
ment on EGFReMAP kinase signalling in infected cells.
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Therefore, AGS cells were pretreated with ILK siRNA and then
stimulated with H pylori WT. Activated EGFR and Erk were
significantly reduced after ILK silencing. These data indicate
that EGFR activation as well as MAP kinase signalling are
linked to CagL binding to avb5-integrin and ILK activation
(figure 5D).
WT H pylori but not DcagL mutant induces a severe antral
gastritis in Mongolian gerbils
To investigate the newly discovered functional role of CagL in
vivo, we used the well established Mongolian gerbil model for
infection studies. For this purpose, Mongolian gerbils were
orogastrically challenged with a suspension of H pylori WTstrain
B8 or an isogenic DcagL mutant. Eight weeks after infection the
animals were sacrificed and longitudinal sections of antral and
corpus mucosa were prepared for haematoxylineeosin staining.
The stained gastric sections of non-infected, WT and DcagL
mutant infected animals were used for grading the inflammation
(figure 7AeC). In this study, we obtained a re-isolation rate of
100% for each strain (data not shown). The gerbil adapted
H pylori WT strain B8 induced severe and moderate inflamma-
tion in antral and corpus mucosa after 8 weeks of infection,
respectively (figure 7B). In contrast, Mongolian gerbils chal-
lenged with an isogenic DcagL mutant strain revealed only
a moderate to severe inflammation in the antrum but not in the
corpus mucosa (figure 7C). These data are consistent with our
previous observations of animals infected with a H pylori
B8DcagY mutant that only reveal a proinflammatory response in
the antral mucosa, after 8 weeks of infection, whereas animals
infected with H pylori WT, carrying a intact T4SS, were able to
induce a corpus dominant gastritis after only 8 weeks of infec-
tion, resulting in a significant hypochlorhydria and hyper-
gastrinaemia after 16 and 32 weeks of infection, respectively.
This indicates a role for CagL in early proinflammatory
responses as major drivers for such physiological changes, as
reported previously.32 33
DISCUSSION
Secreted gastrin is a crucial hormone in mammals and regulates
not only the pH of the stomach but also the growth and
differentiation of gastric epithelial cells.56 H pylori induced
hypergastrinaemia was postulated to be a major risk factor
promoting the development of gastric cancer.24 32 33 57 To date
the mechanism by which H pylori induces the gastrin signalling
pathway is poorly understood. To elucidate how H pylori induces
gastrin gene expression, an in vitro promoter study was
performed. We report here the identification of a bacterial factor,
CagL, which can activate a novel integrin linked signalling
cascade to induce gastrin secretion as recombinant protein in
vitro and during infection in vivo.
Figure 5 Integrin linked kinase (ILK) is
involved in H pylori induced gastrin
gene expression. (A) AM0 cells were
transfected with either ILK small
interfering RNA (siRNA 50 nM) or focal
adhesion kinase (FAK) siRNA (50 nM)
for 24 h. RNA was isolated and RT-PCR
was performed. Control siRNA (50 nM)
with the same GC content as the ILK
siRNA or FAK siRNA was used as
knockdown negative control
(represents 100%). (B) Western blot
analyses were performed to confirm ILK
or FAK silencing on protein level.
a-tubulin (Tub) served as a loading
control. (C) AM0 cells were transfected
with control siRNA (50 nM), FAK siRNA
(50 nM) and ILK siRNA (50 nM) for 72 h
and subsequently stimulated with H
pylori B8 strain. Luciferase activities in
relation to H pylori B8 wild-type (WT)
transfected with control siRNA
(represents 100%; interpolated broken
line) were plotted. (D) Western blot
analyses of AGS cells preincubated
with control siRNA or ILK siRNA and
stimulated with H pylori P12 were
performed to detect ILK silencing,
activation of epidermal growth factor
receptor (EGFR) and extracellular signal
regulated kinase (ERK), and loading
control GAPDH using specific
antibodies. Relative quantification of
expressed phosphorylated EGFR and
ERK (lower graph). The mean values 6
SEM of at least three independent
experiments are shown. Statistical
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Our data demonstrate for the first time that H pylori uses
a avb5-integrineILK signalling complex to induce gastrin
expression. We have shown that avb5-integrin is a novel human
receptor exploited by a bacterial pathogen to induce precan-
cerous conditions in gastric epithelial cells. Kwok et al found
that b1-integrin functioned as an important receptor for binding
of the H pylori T4SS to host cells. The authors demonstrated
that this interaction triggers CagA translocation into the host
cells and activates the downstream cascade via FAK and Src.6 In
the present study, we established that T4SS, but not b1-integrin
receptor or the FAK/Src cascade, plays a major role in gastrin
promoter induction. In contrast, by means of silencing, blocking
and immunoprecipitation experiments, a newly discovered
interaction could be identified between H pylori WT and avb5-
integrin that was followed by an ILK dependent downstream
signalling cascade. A series of experiments, including function
blocking antibodies, siRNA and inhibitors conclusively revealed
that H pylori induced gastrin promoter activation involves
EGFR followed by an MEK/Erk signalling cascade, but seems
independent of EGF itself.
Using a variety of mutant H pylori strains during infection,
our data revealed that the major bacterial virulence factors
CagA, VacA, BabA, SabA and AlpA/B are not required for
induction of gastrin gene expression. However, binding of
H pylori WT strains carrying an intact T4SS of the cagPAI was
necessary to induce the gastrin promoter. This is in agreement
with several patient studies demonstrating that the H pylori
CagA status, linked to the presence of the entire cagPAI, is
correlated with an increased plasma gastrin level in gastritis and
gastric cancer patients.58e61 Those observations raised the
question which bacterial T4SS factor is essential for gastrin gene
induction on binding to avb5-integrin. Several lines of evidence
presented here demonstrate that this factor is CagL. Firstly,
deletion of cagL gene in H pylori causes loss of gastrin promoter
activation during infection of AM0 cells. Secondly, immuno-
precipitation experiments during infection demonstrate that
CagL forms a physical complex with avb5-integrin. Thirdly,
purified recombinant CagL alone is sufficient to induce gastrin
promoter activation on contact with AM0 cells. Fourthly, our
Biacore proteineprotein interaction studies in vitro demonstrate
that CagL binds with very high affinity to avb5 integrin
(KD¼0.20 mM). Fifthly, recombinant CagL alone, on binding
to avb5-integrin, triggers profound activation of the
EGFR/Raf/MEK/Erk signalling cascade upstream of the
gastrin promoter.
Apart from the fact that CagL triggers avb5-integrin medi-
ated gastrin promoter activation, our study suggests that this
signalling proceeds by an intriguing RGD independent mech-
anism. The first report demonstrating the importance of CagL,
which is located at the surface of the T4SS injection pilus,
inducing the translocation of the oncoprotein CagA in a RGD
dependent manner,6 let us originally propose that the
CagL dependent activation of the gastrin promoter might be
RGD dependent also. To our surprise, applying several different
isogenic H pylori mutant strains that carry a mutated or total
deleted RGD motif of the cagL gene, exhibited strong gastrin
induction compared with WT levels. In line with these
observations, both WT CagL and mutated CagLRGA bound
with similarly strong affinity to avb5-integrin, both during
infection in vivo (as supported by IP experiments) and as
Figure 6 Epidermal growth factor
receptor (EGFR)/Raf/mitogen activated
protein kinase kinase (MEK)/
extracellular signal regulated kinase
(ERK) protein kinases are involved in H
pylori induced gastrin promoter
activation. (A) AM0 cells were
preincubated with ZM336372 (50 mM),
PD98059 (50 mM) or SB203580
(25 mM) and stimulated with H pylori
B8 strain. (B) Western blot analyses
were performed to show H pylori
induced phosphorylation of Erk and
p38. Erk signalling was inhibited by
using PD98059 (100 mM). a-tubulin
(Tub) served as a loading control. (C)
Western blot analyses of AGS cells
stimulated with recombinant H pylori
wild-type (WT) CagL (5 mg) applying
antibodies against phosphorylated
forms of EGFR, Raf, MEK1 and ERK. a-
GAPDH antibody was used as a loading
control. (D) AM0 cells were
preincubated with a-EGF antibody,
gefitinib or AG1478 and stimulated with
H pylori B8. Luciferase activities in
relation to H pylori B8 WT (represents
100%) were plotted. The mean values
6 SEM of at least three independent
experiments are shown. Statistical
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purified proteins in vitro (as supported by Biacore binding
studies).
The development of gastric cancer is a highly complex process
and proinflammatory cytokines play an important role in the
progression of precancerous conditions. In our recently
published animal study it was shown that H pylori B8 WTstrain
can induce an early and severe inflammation in antral and corpus
mucosa that is associated with increased expression of proin-
flammatory cytokines.32 In contrast, isogenic H pylori mutant
strains with a defective T4SS revealed an early moderate to
severe inflammation only in the antral but not in the corpus
mucosa. This indicates that induction of early inflammation in
the corpus mucosa by H pylori is part of a pathomechanism
which causes later precancerous physiological changes, such as
hypochlorhydria and hypergastrinaemia. These observations
demonstrate that an infection of 8 weeks is sufficient to
distinguish between bacterial factors harbouring a risk factor for
developing cancerous conditions or not. As shown in the in vivo
part of this study, DcagL mutants revealed strongly attenuated
responses compared with WT bacteria. Thus CagL, a functional
protein of the T4SS, is an essential bacterial ligand interacting
with the host receptor family b-integrin to induce precancerous
conditions.
The question arises how our newly discovered in vitro data
can be extrapolated to understand the interactions of H pylori
with G cells and gastrin production in vivo. It is known that
H pylori is able to release proteases and other soluble factors that
open the tight and adherence junctions of epithelial cells.62 This
enables the bacteria to reach the basolateral side of the cells
where integrin is expressed. We assume a comparable mecha-
nism regarding G cells and their stimulation by H pylori. This is
not an early side effect of infection but requires a solid coloni-
sation of H pylori with a severe inflammation associated with
histopathological changes of the gastric mucosa. The occurrence
of hypergastrinaemia in our in vivo experiments was based on
a late physiological change due to an infection with H pylori type
I strain.
Taken together, in this report we characterised a novel
pathway leading to H pylori induced gastrin promoter activation
and presented evidence for a new role of the CagL protein to
induce the gastrin promoter in a avb5-integrin dependent
manner. These findings represent an important H pylori associ-
ated signalling cascade in gastrin gene induction. Using
a combination of in vitro and in vivo experiments, we elucidated
a H pylori induced upstream signalling pathway of the gastrin
promoter via the EGFR/Raf/MEK/Erk cascade. In a time of
increasing H pylori antibiotic resistance, the newly discovered
interaction of H pylori CagL with avb5-integrin could be a useful
target in treating gastric precancerous conditions triggered by
H pylori induced hypergastrinaemia.
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Figure 7 CagL deficiency prevents inflammation in corpus mucosa of infected Mongolian gerbils. Haematoxylineeosin stained paraffin embedded
antral and corpus tissue of (A) non-infected, (B) H pylori B8 and (C) isogenic B8DcagL mutant strain infected Mongolian gerbils for 8 weeks (original
magnification 310).
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